Prof Maiken Cavling Arendrup obtained her medical degree from Copenhagen University, Denmark, in 1988, followed by a PhD degree on neutralizing antibodies and HIV infection in 1992. In 2001, she completed further training as a specialist in clinical microbiology and in September 2013 her doctoral thesis on epidemiology and susceptibility of candidaemia was defended for the Dr. Med. Sci degree.
Currently, Dr. Arendrup is Professor at the University Hospital Rigshospitalet in Copenhagen and the Head of the Mycology Unit at Statens Serum Institut, Copenhagen, where she is responsible for the fungal laboratory, which receives 13,000 routine and reference samples per year for culture, susceptibility testing, antigen- and antibody-detection, and PCR as well as for the semi-national surveillance of invasive fungal infections and azole resistance in Aspergillus. She is responsible for the supervision of several PhD students.
Prof Arendrup was the founder of the Nordic Society of Medical Mycology (NSMM) and has been president since the formation of the society in 2003 till 2018. She is chair of the EUCAST Antifungal Susceptibility Testing Subcommittee Steering Committee, head of the EUCAST Development Laboratory for fungi, and an editor for Drug Resistance Updates. In 2005-9 and 2011-13 she has served as a European Confederation of Medical Mycology (ECMM) delegate on the executive organizing committee for TIMM-3 and 4 and as delegate for NSMM for the TIMM 6 in Copenhagen. She was on the organizing committee for international scientific committee for TIMM 7 in Lisbon. Moreover she has served as advisor for the CLSI committee for 4 years ending in 2014 and was on the programme committee for the ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance 2018 and 2019. In 2017 she was appointed Fellow of the European Society for Clinical Microbiology and Infectious Diseases.
Prof Arendrup has authored around 225 publications in international journals and as book chapters. She has received two research awards (Fritz Kauffman’s reward in 2003 and The Danish Society for Clinical Microbiology’s research award in 2010). Her main research interests include the epidemiology, susceptibility, breakpoint development, diagnostics and treatment of fungal infections.